CVRx, Inc. (CVRX) vs LENSAR, Inc. (LNSR)
CVRx, Inc. and LENSAR, Inc. are both Medical Devices companies. LENSAR, Inc. is the larger, with a market value of $86.9M against $67.4M — 1.3× the size. CVRx, Inc. has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 2.4×. CVRx, Inc. grew revenue faster over the last twelve months: 12.0% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −84.9%) and the lower return on invested capital (−379.0% vs −218.1%). Across the 18 metrics below, CVRx, Inc. leads on 11 and LENSAR, Inc. on 7.
Valuation
Profitability
| Metric | CVRX | LNSR | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.92% | 48.34% | 56.01% |
| Operating margin | (79.49%) | (13.48%) | (15.03%) |
| Net margin | (84.93%) | 57.57% | (20.40%) |
| Free cash flow margin | (67.09%) | (12.29%) | (7.24%) |
| Return on equity | (133.44%) | (851.75%) | (15.32%) |
| Return on assets | (49.06%) | 49.58% | (19.72%) |
| Return on invested capital | (218.09%) | (379.01%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack